Correlation Between Artiva Biotherapeutics, and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Artiva Biotherapeutics, and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artiva Biotherapeutics, and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artiva Biotherapeutics, Common and Fate Therapeutics, you can compare the effects of market volatilities on Artiva Biotherapeutics, and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artiva Biotherapeutics, with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artiva Biotherapeutics, and Fate Therapeutics.
Diversification Opportunities for Artiva Biotherapeutics, and Fate Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Artiva and Fate is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Artiva Biotherapeutics, Common and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Artiva Biotherapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artiva Biotherapeutics, Common are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Artiva Biotherapeutics, i.e., Artiva Biotherapeutics, and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Artiva Biotherapeutics, and Fate Therapeutics
Given the investment horizon of 90 days Artiva Biotherapeutics, Common is expected to generate 0.93 times more return on investment than Fate Therapeutics. However, Artiva Biotherapeutics, Common is 1.08 times less risky than Fate Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 1,200 in Artiva Biotherapeutics, Common on September 25, 2024 and sell it today you would lose (152.00) from holding Artiva Biotherapeutics, Common or give up 12.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 22.33% |
| Values | Daily Returns |
Artiva Biotherapeutics, Common vs. Fate Therapeutics
Performance |
| Timeline |
| Artiva Biotherapeutics, |
| Fate Therapeutics |
Artiva Biotherapeutics, and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Artiva Biotherapeutics, and Fate Therapeutics
The main advantage of trading using opposite Artiva Biotherapeutics, and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artiva Biotherapeutics, position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Artiva Biotherapeutics, vs. Fate Therapeutics | Artiva Biotherapeutics, vs. Caribou Biosciences | Artiva Biotherapeutics, vs. Arcus Biosciences | Artiva Biotherapeutics, vs. Karyopharm Therapeutics |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |